← Back to headlines
Sangamo Aims for Fabry BLA Submission by Summer 2026, Advances Neurology Pipeline
Sangamo Therapeutics is targeting summer 2026 for its Fabry BLA submission while continuing to advance its neurology pipeline and engage in partner discussions.
30 Mar, 22:22 — 30 Mar, 22:22
Sources
Showing 1 of 1 sources
Related Stories
Heat Index in Cotabato City Expected to Reach 41°C, Placing 70 Areas on Alert
just now
Zamboanga City Island Residents Gain Access to Safe Water
just now
Detransitioner Chloe Cole Accuses Media of Suppressing Coverage of Transgender Shooters
32m ago
White House Reaffirms Support for Surgeon General Nominee Casey Means
54m ago